NASDAQ: SPRYRUSSELL2000

ARS Pharmaceuticals, Inc.

Healthcare · Biotechnology · Headquartered in San Diego, US

Price

Loading chart…

Overview

ARS Pharmaceuticals, Inc. specializes in creating ARS-1, an innovative intranasal epinephrine spray utilizing advanced absorption technology. This product serves as a crucial intervention for individuals and their households who are susceptible to life-threatening allergic reactions caused by food, pharmaceuticals, or insect stings. Among its offerings is Neffy, a low-dose version of its intranasal epinephrine nasal spray. Established in 2015, the firm operates out of San Diego, California.

History & business model

This section is waiting to be written.

InvestWiki is community-edited. Contribute a plain-English history of ARS Pharmaceuticals, Inc., its business model, key products, and controversies.

Write this articleSign in required. Edits go to moderator review.View history →